Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure? - PubMed (original) (raw)

Editorial

Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure?

M Packer. Circulation. 1995.

No abstract available

PubMed Disclaimer

Comment on

• Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure.
  Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, Corti A, Cassani G, Visioli O. Ferrari R, et al. Circulation. 1995 Sep 15;92(6):1479-86. doi: 10.1161/01.cir.92.6.1479. Circulation. 1995. PMID: 7664430

Similar articles

• Tumour necrosis factor as a potential target for the treatment of congestive heart failure.
  Visioli F. Visioli F. Pharmacol Res. 1999 Aug;40(2):91. doi: 10.1006/phrs.1998.0462. Pharmacol Res. 1999. PMID: 10433865 No abstract available.
• [Anti-TNF-alpha therapy for heart failure: etanercept, infliximab].
  Matsumori A. Matsumori A. Nihon Rinsho. 2007 May 28;65 Suppl 5:176-81. Nihon Rinsho. 2007. PMID: 17569314 Review. Japanese. No abstract available.
• [Tumor necrosis factor and heart failure].
  Ferrari R. Ferrari R. Cardiologia. 1998 Feb;43(2):143-55. Cardiologia. 1998. PMID: 9557370 Review. Italian. No abstract available.
• [New concept in chronic heart failure. Blocking the function of tumor necrosis factor].
  [No authors listed] [No authors listed] MMW Fortschr Med. 2000 Mar 30;142(13):51. MMW Fortschr Med. 2000. PMID: 10783628 German. No abstract available.
• Clinical implications of tumour necrosis factor alpha antagonism in patients with congestive heart failure.
  Torre-Amione G, Stetson SS, Farmer JA. Torre-Amione G, et al. Ann Rheum Dis. 1999 Nov;58 Suppl 1(Suppl 1):I103-6. doi: 10.1136/ard.58.2008.i103. Ann Rheum Dis. 1999. PMID: 10577985 Free PMC article. Review. No abstract available.

Cited by

• Heart failure in 10 years time: focus on pharmacological treatment.
  McMurray JJ. McMurray JJ. Heart. 2002 Oct;88 Suppl 2(Suppl 2):ii40-6. doi: 10.1136/heart.88.suppl_2.ii40. Heart. 2002. PMID: 12213800 Free PMC article. Review. No abstract available.
• Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy.
  Node K, Fujita M, Kitakaze M, Hori M, Liao JK. Node K, et al. Circulation. 2003 Aug 19;108(7):839-43. doi: 10.1161/01.CIR.0000084539.58092.DE. Epub 2003 Jul 28. Circulation. 2003. PMID: 12885745 Free PMC article. Clinical Trial.
• omega-3 polyunsaturated fatty acid supplementation for the treatment of heart failure: mechanisms and clinical potential.
  Duda MK, O'Shea KM, Stanley WC. Duda MK, et al. Cardiovasc Res. 2009 Oct 1;84(1):33-41. doi: 10.1093/cvr/cvp169. Epub 2009 May 27. Cardiovasc Res. 2009. PMID: 19474179 Free PMC article. Review.
• Statins in heart failure: do we need another trial?
  Bonsu KO, Kadirvelu A, Reidpath DD. Bonsu KO, et al. Vasc Health Risk Manag. 2013;9:303-19. doi: 10.2147/VHRM.S44499. Epub 2013 Jun 17. Vasc Health Risk Manag. 2013. PMID: 23807852 Free PMC article. Review.
• Venous congestion, endothelial and neurohormonal activation in acute decompensated heart failure: cause or effect?
  Colombo PC, Doran AC, Onat D, Wong KY, Ahmad M, Sabbah HN, Demmer RT. Colombo PC, et al. Curr Heart Fail Rep. 2015 Jun;12(3):215-22. doi: 10.1007/s11897-015-0254-8. Curr Heart Fail Rep. 2015. PMID: 25740404 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information